NCT00544258View on ClinicalTrials.gov

Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Actinic Keratoses
Interventions
DRUG

PEP005

Trial Locations (1)

4000

Siller Medical, Silverton Place, 101 Wickham Terrace, Brisbane

Sponsors

Lead Sponsor

Peplin
All Listed Sponsors
lead

Peplin

INDUSTRY

NCT00544258 - Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 | Biotech Hunter | Biotech Hunter